Market capitalization | CHF208.68m |
Enterprise Value | CHF425.52m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.42 |
P/S ratio (TTM) P/S ratio | 0.21 |
P/B ratio (TTM) P/B ratio | 0.61 |
Revenue growth (TTM) Revenue growth | 4.91% |
Revenue (TTM) Revenue | CHF1.02b |
As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.
12 Analysts have issued a DocMorris forecast:
12 Analysts have issued a DocMorris forecast:
Dec '24 |
+/-
%
|
||
Revenue | 1,017 1,017 |
5%
5%
|
|
Gross Profit | 71 71 |
43%
43%
|
|
EBITDA | -44 -44 |
14%
14%
|
EBIT (Operating Income) EBIT | -90 -90 |
8%
8%
|
Net Profit | -97 -97 |
14%
14%
|
In millions CHF.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
DocMorris Ltd. engages in the operation of an e-commerce pharmacy and the wholesale of medical and pharmaceutical products. It operates through the following geograpical segments: Switzerland, Germany, and Europe. The company was founded by Walter Oberhänsli on April 6, 1993 and is headquartered in Frauenfeld, Switzerland.
Head office | Switzerland |
CEO | Walter Hess |
Employees | 1,454 |
Founded | 1993 |
Website | corporate.docmorris.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.